Neuromyelitis optica (NMO) refers to a condition where the immune system attacks myelin in the CNS, mainly affecting nerves in the eyes and the spinal cord. Health experts may also refer to NMO as ...

At ECTRIMS 2024, Dr Joseph R. Berger hopes to see clinical updates on optimal treatment strategies and biomarker advancements for neuromyelitis optica spectrum disorders.

Neuromyelitis optica spectrum disorder (NMOSD) and related demyelinating diseases, including myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), represent a spectrum of ...

Of all the patients with NMOSD, 77% had brain magnetic resonance imaging within 3 months before participation; white matter lesions were then qualified with the Fazekas Scale, which has 4 degrees ...